Search Results - "Boon, Eline"

A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands by Boon, Eline, Bel, Miranda, van Boxtel, Wim, van der Graaf, Winette T. A., van Es, Robert J. J., Eerenstein, Simone E. J., Baatenburg de Jong, Robert J., van den Brekel, Michiel W. M., van der Velden, Lilly‐Ann, Witjes, Max J. H., Hoeben, Ann, Willems, Stefan M., Bloemena, Elisabeth, Smit, Laura A., Oosting, Sjoukje F., Jonker, Marianne A., Flucke, Uta E., van Herpen, Carla M. L.

“…Salivary duct carcinoma (SDC) is a subtype of salivary gland cancer with a dismal prognosis and a need for better prognostication and novel treatments. The aim…”
Get full text

Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands by Boon, Eline, van Boxtel, Wim, Buter, Jan, Baatenburg de Jong, Robert J., van Es, Robert J. J., Bel, Miranda, Fiets, Edward, Oosting, Sjoukje F., Slingerland, Marije, Hoeben, Ann, Tesselaar, Margot E. T., Jonker, Marianne A., Flucke, Uta E., van der Graaf, Winette T. A., van Herpen, Carla M. L.

“…Background Salivary duct carcinoma, an aggressive subtype of salivary gland cancer, is mostly androgen receptor‐positive. Only limited data are available on…”
Get full text

Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults by Boon, Eline, van der Graaf, Winette T. A., Gelderblom, Hans, Tesselaar, Margot E. T., van Es, Robert J. J., Oosting, Sjoukje F., de Bree, Remco, van Meerten, Esther, Hoeben, Ann, Smeele, Ludi E., Willems, Stefan M., Witjes, Max J. H., Buter, Jan, Baatenburg de Jong, Robert J., Flucke, Uta E., Peer, Petronella G. M., Bovée, Judith V. M. G., Van Herpen, Carla M. L.

“…Background There is an ongoing debate about the value of (neo‐)adjuvant chemotherapy in high‐ and intermediate‐grade osteosarcoma of the head and neck. Methods…”
Get full text

RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer by Helden, Erik J., Angus, Lindsay, Menke‐van der Houven van Oordt, C. Willemien, Heideman, Daniëlle A. M., Boon, Eline, Es, Suzanne C., Radema, Sandra A., Herpen, Carla M. L., Groot, Derk Jan A., Vries, Elisabeth G. E., Jansen, Maurice P. H. M., Sleijfer, Stefan, Verheul, Henk M. W.

“…In metastatic colorectal cancer, RAS and BRAF mutations cause resistance to anti‐EGFR therapies, such as cetuximab. Heterogeneity in RAS and BRAF mutations…”
Get full text

Structural differences between two types of basidiomycete septal pore caps by Muller, W.H, Montijn, R.C, Humbel, B.M, Aelst, A.C. van, Boon, E.J.M.C, Krift, T.P. van der, Boekhout, T

“…The septal pore cap (SPC) of Trichosporon sporotrichoides CBS 8245 is vesicular-tubular, connected with flat-tubular endoplasmic reticulum (ER), and stains…”
Get full text

Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma by Verhoeff, Sarah R., van Es, Suzanne C., Boon, Eline, van Helden, Erik, Angus, Lindsay, Elias, Sjoerd G., Oosting, Sjoukje F., Aarntzen, Erik H., Brouwers, Adrienne H., Kwee, Thomas C., Heskamp, Sandra, Hoekstra, Otto S., Verheul, Henk, van der Veldt, Astrid A. M., de Vries, Elisabeth G. E., Boerman, Otto C., van der Graaf, Winette T. A., Oyen, Wim J. G., van Herpen, Carla M. L.

“…Purpose The main objective of this preliminary analysis of the IMaging PAtients for Cancer drug selecTion (IMPACT)-renal cell cancer (RCC) study is to evaluate…”
Get full text

Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results by van Es, Suzanne C, van der Vegt, Bert, Bensch, Frederike, Gerritse, Sophie, van Helden, Erik J, Boon, Eline, Angus, Lindsay, Overbosch, Jelle, Menke-van der Houven van Oordt, Catharina W, Verheul, Henk M, van Herpen, Carla M.L, Jager, Agnes, Oosting, Sjoukje F, de Vries, Elisabeth G.E, Schröder, Carolina P

“…In metastatic breast cancer (MBC), expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) guides…”
Get full text

Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma by van Boxtel, Wim, Boon, Eline, Weijs, Willem L.J., van den Hoogen, Frank J.A., Flucke, Uta E., van Herpen, Carla M.L.

Get full text

Muscle cramps and contractures: causes and treatment by Dijkstra, Jildou N, Boon, Eline, Kruijt, Nick, Brusse, Esther, Ramdas, Sithara, Jungbluth, Heinz, van Engelen, Baziel G M, Walters, Jon, Voermans, Nicol C

“…Muscle cramps are painful, sudden, involuntary muscle contractions that are generally self-limiting. They are often part of the spectrum of normal human…”
Get more information

Prognostic factors for overall survival of patients with head and neck soft tissue sarcoma based on 25 years data from the Netherlands Cancer registry by Ten Thije, Lotte, Boon, Eline, Desar, Ingrid, Flucke, Uta E, van der Graaf, Winette TA, Ho, Vincent K.Y., Van Herpen, Carla M.L.

“…Abstract only…”
Get full text

Change in metabolic tumor activity on 18 F-FDG PET after a single dose of cetuximab to predict for treatment benefit, PFS, and OS in patients with advanced colorectal cancer by Van Helden, Erik Jacobus, Menke, Catharina Wilhelmina, Boon, Eline, van Es, Suzanne, Huisman, Marc C., De Groot, Derk Jan, Boellaard, Ronald, Van Herpen, Carla M.L.-, De Vries, Elisabeth, Hoekstra, Otto S., Verheul, Henk M.W.

“…Abstract only 11519 Background: Despite RAS selection, one third of patients with metastatic RAS wild-type colorectal cancer (mCRC) do not benefit from…”
Get full text

Pharmacokinetics of cetuximab and tumor uptake of 89 Zr-cetuximab as potential predictive biomarkers for benefit of cetuximab in patients with advanced colorectal cancer by Van Helden, Erik Jacobus, Menke, Catharina Wilhelmina, Boon, Eline, van Es, Suzanne, Huisman, Marc C., Dongen, G.a.M.S. van, Vugts, Danielle J., De Groot, Derk Jan, Van Herpen, Carla M.L.-, De Vries, Elisabeth, Hoekstra, Otto S., Verheul, Henk M.W.

“…Abstract only e15117 Background: One third of patients with RAS wild-type metastatic colorectal cancer (mCRC) do not benefit from anti-EGFR inhibitors. Thus,…”
Get full text

A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from T he N etherlands by Boon, Eline, Bel, Miranda, van Boxtel, Wim, van der Graaf, Winette T. A., van Es, Robert J. J., Eerenstein, Simone E. J., Baatenburg de Jong, Robert J., van den Brekel, Michiel W. M., van der Velden, Lilly‐Ann, Witjes, Max J. H., Hoeben, Ann, Willems, Stefan M., Bloemena, Elisabeth, Smit, Laura A., Oosting, Sjoukje F., Jonker, Marianne A., Flucke, Uta E., van Herpen, Carla M. L.

“…Salivary duct carcinoma (SDC) is a subtype of salivary gland cancer with a dismal prognosis and a need for better prognostication and novel treatments. The aim…”
Get full text

Different ratios of sucrose/raffinose-induced membrane depolarizations in the mesophyll of species with symplasmic (Catharanthus roseus, Ocimum basilicum) or apoplasmic (Impatiens walleriana, Vicia faba) minor-vein configurations by van Bel, Aart J.E., Hendriks, Janneke H.M., Boon, Eline J.M.C., Gamalei, Yuri V., van de Merwe, Arjan Ph

“…In mesophyll cells of species with a symplasmic (Ocimum basilicum, Catharanthus roseus, Magnolia denudata) or an apoplasmic (Vicia faba, Impatiens walleriana,…”
Get full text

Salivary duct carcinoma: Clinical outcomes and prognostic factors in 157 patients and results of androgen deprivation therapy in recurrent disease (n=31)—Study of the Dutch head and neck society (DHNS) by Boon, Eline, Bel, Miranda, van der Graaf, Winette TA, van Es, Robert J.J., Eerenstein, Simone, Baatenburg De Jong, Robert, van den Brekel, Michiel, van der Velden, Lilly-Ann, Witjes, Max, Hoeben, Ann, Willems, Stefan M., Bloemena, Elisabeth, Smit, Laura, Oosting, Sjoukje, Flucke, Uta E, Van Herpen, Carla M.L.

“…Abstract only…”
Get full text

Osteosarcoma of the head and neck (OHN): A multicenter case series of 79 adult patients in the Netherlands by Boon, Eline, Van Der Graaf, Winette T.A., Gelderblom, Hans, Tesselaar, Margot Et, van Es, Robert J.J., Oosting, Sjoukje, De Bree, Remco, Meerten, Esther Van, Hoeben, Ann, Flucke, Uta E., Bovée, Judith V.M.G., Van Herpen, Carla M.L.-

“…Abstract only…”
Get full text

Abstract OT3-2-01: IMPACT: IMaging PAtients for Cancer drug selecTion – Metastatic breast cancer (MBC) by Bensch, Frederike, Brouwers, Adrienne, Glaudemans, Andor, de Jong, Johan, de Vries, Erik, van de Graaf, Winette, Boon, Eline, Oyen, Wim, de Geus-Oei, Lioe-Fee, Visser, Eric, van Helden, Erik, Menke-van der Hoeven van Oordt, Willemien, Verheul, Henk, Hoekstra, Otto, Janssen, Jim, Huisman, Marc, Elias, Sjoerd, Moons, Carl, de Vries, Liesbeth, Schröder, Carolien

“…Abstract Background: Therapy of newly identified MBC is largely based on estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status…”
Get full text